See more : Poolia AB (publ) (POOL-B.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Cuorips Inc. (4894.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cuorips Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- The9 Limited (FZKA.F) Income Statement Analysis – Financial Results
- St. Joseph, Inc. (STJO) Income Statement Analysis – Financial Results
- Kerjaya Prospek Group Bhd (7161.KL) Income Statement Analysis – Financial Results
- Victory Securities (Holdings) Company Limited (8540.HK) Income Statement Analysis – Financial Results
- Capital Clean Energy Carriers Corp. (CCEC) Income Statement Analysis – Financial Results
Cuorips Inc. (4894.T)
About Cuorips Inc.
Cuorips Inc. engages in the research, development, manufacture, commercialization, and sale of iPS cell-derived cardiomyocyte sheets. The company offers cellular and tissue-based, and cell processing products. It also provides contract development and manufacturing, and consulting services. The company was formerly known as Cuore Inc. and changed its name to Cuorips Inc. in June 2017. Cuorips Inc. was incorporated in 2017 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 23.10M | 38.28M | 13.91M | 220.00K |
| Cost of Revenue | 13.47M | 17.27M | 3.26M | 82.00K |
| Gross Profit | 9.63M | 21.01M | 10.65M | 138.00K |
| Gross Profit Ratio | 41.69% | 54.89% | 76.57% | 62.73% |
| Research & Development | 0.00 | 168.00M | 112.81M | 72.62M |
| General & Administrative | 0.00 | 471.45M | 383.92M | 281.98M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 598.00M | 471.45M | 383.92M | 281.98M |
| Other Expenses | 0.00 | 5.00K | 111.00K | 20.00K |
| Operating Expenses | 598.12M | 471.45M | 383.92M | 281.98M |
| Cost & Expenses | 611.59M | 488.71M | 387.18M | 282.06M |
| Interest Income | 45.00K | 11.00K | 0.00 | 0.00 |
| Interest Expense | 19.47M | 0.00 | 0.00 | 765.00K |
| Depreciation & Amortization | 70.10M | 78.66M | 92.74M | 73.91M |
| EBITDA | -518.00M | -371.78M | -280.40M | -221.17M |
| EBITDA Ratio | -2,242.23% | -972.67% | -2,015.39% | -100,530.00% |
| Operating Income | -588.49M | -450.44M | -373.26M | -281.84M |
| Operating Income Ratio | -2,547.34% | -1,176.75% | -2,682.84% | -128,109.09% |
| Total Other Income/Expenses | -41.47M | 557.00K | 124.00K | -14.01M |
| Income Before Tax | -629.95M | -449.88M | -373.14M | -295.85M |
| Income Before Tax Ratio | -2,726.83% | -1,175.29% | -2,681.95% | -134,475.00% |
| Income Tax Expense | 2.23M | 2.20M | 2.20M | 11.99M |
| Net Income | -632.18M | -452.08M | -375.34M | -307.83M |
| Net Income Ratio | -2,736.49% | -1,181.04% | -2,697.74% | -139,924.55% |
| EPS | -85.87 | -59.94 | -49.76 | -40.81 |
| EPS Diluted | -85.87 | -59.94 | -49.76 | -40.81 |
| Weighted Avg Shares Out | 7.36M | 7.54M | 7.54M | 7.54M |
| Weighted Avg Shares Out (Dil) | 7.36M | 7.54M | 7.54M | 7.54M |
Source: https://incomestatements.info
Category: Stock Reports